Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

March 27, 2018 5:05 pm Published by redakteur

Nystrom A, Thriene K, Mittapalli V, Kern JS, Kiritsi D, Dengjel J, Bruckner-Tuderman L (2015) Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms. EMBO Mol Med 7: 1211-28

Categorised in:

This post was written by redakteur

Get in contact

Coordinator
Prof. Dr. Christoph Peters
University of Freiburg

+49 (0)761 / 203 9600 christoph.peters@mol-med.uni-freiburg.de